Glycine

Glycine

SCHEMBL5712832

NCC(=O)O.[KH].[KH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL22949 1.00
Glycine SCHEMBL4274286 1.00 GLRA1 (0.91)
Glycine SCHEMBL6396455 0.96
Glycine SCHEMBL29168877 0.96
Glycine SCHEMBL28665130 0.96
Glycine SCHEMBL583141 0.96 GLRA1 (0.83)
Glycine SCHEMBL3640989 0.95 GLRA1 (1.00)
Glycine SCHEMBL391786 0.95 GLRA1 (1.00)
Glycine SCHEMBL93765 0.95 GLRA1 (1.00)
Glycine SCHEMBL391027 0.95 GLRA1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648390-A2 COMPOSITIONS CONTAINING MELON EXTRACTS GUTHY-RENKER CORPORATION (US) 2006-04-26 EP disclosed
WO-2005046574-A2 COMPOSITIONS CONTAINING MELON EXTRACTS GUTHY-RENKER CORPORATION (US) 2005-05-26 WO disclosed